FIELD: chemistry.
SUBSTANCE: invention relates to a novel 6-methyl-1-(1-oxothietan-3-yl)uracil in the form of a mixture of cis- and trans-isomers in molar ratio of 10:1.
EFFECT: compound exhibits hypotensive activity and corresponds to said formula.
2 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ETHYLIDENE HYDRAZIDE OF 2-[6-METHYL-1-(THIETHAN-3-YL)URACYL-3-YL]ACETIC ACID, DEMONSTRATING HYPOTENSIVE ACTIVITY | 2013 |
|
RU2539301C1 |
| METHOD FOR OPTIMISATION OF MEN CARDIOTROPIC THERAPY AND HORMONE REPLACEMENT THERAPY IN CASE OF ANDROGENODEFICIENCY WITH ARTERIAL HYPERTENSION | 2016 |
|
RU2632449C1 |
| METHOD OF OPTIMIZATION OF TREATMENT OF WOMEN BY CARDIOTROPIC THERAPY AND HORMONE REPLACEMENT THERAPY FOR ESTROGENDEFICIENCY WITH HYPERTENSION IN THE LATE REPRODUCTIVE PERIOD | 2016 |
|
RU2648470C2 |
| PROLONGED ANTIHYPERTENSION PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING IT | 2012 |
|
RU2543637C2 |
| METHOD FOR INDIVIDUAL SELECTION OF DRUG PREPARATIONS IN THERAPY OF ARTERIAL HYPERTENSION | 2011 |
|
RU2477974C2 |
| METHOD OF TREATING ESSENTIAL ARTERIAL HYPERTENSION AT BACKGROUND OF OBESITY | 2013 |
|
RU2563832C2 |
| METHOD FOR PREDICTION OF MEDICAL-SOCIAL EFFECTIVENESS OF INTEGRATED TREATMENT IN PATIENTS WITH ARTERIAL HYPERTENSION | 2012 |
|
RU2522389C1 |
| METHOD FOR PROVIDING HIGHER EFFICACY AND SAFETY OF ULTRAFAST OPIOID DETOXIFICATION | 2012 |
|
RU2524421C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF HYPERTONIC DISEASE (HD) OF II STAGE AND ITS TREATMENT | 2011 |
|
RU2481062C1 |
| METHOD FOR PATIENT-SPECIFIC PREDICTION OF OESTROGEN-DEPENDENT DISEASES IN HEALTHY FEMALES AND FEMALES WITH CARDIOVASCULAR RISK FACTORS AGED 35-45 YEARS | 2013 |
|
RU2536829C1 |
